EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR‐486‐5p/NEK2 axis

Haoyu Fu iD, Mingming Zhang, Xiaohui Liu, Yiming Yang, Ying Xing

The Clinical Respiratory Journal · 2024

DOI: 10.1111/crj.13765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2024. Verfasst von Haoyu Fu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Tangshan People's Hospital, Tangshan, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cell Proliferation, Disease Progression, DNA Methylation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Project Program of Medical Science Research in Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LINC00857 is frequently dysregulated in varying cancers, which in turn exerts carcinogenic effects; however, its DNA methylation status in promoter region and molecular mechanisms underlying the progression of lung adenocarcinoma (LUAD) remain rarely understood. Through bioinformatics analysis, we examined the expression state and methylation site of LINC00857 in LUAD and further investigated the properties of LINC00857 as a competitive endogenous RNA in the cancer progression. The current study revealed that the overexpression of LINC00857 in LUAD tissue and cells was mainly caused by the hypomethylation of the promoter region. LINC00857 knockdown prominently reduced cell proliferation, impeded cell migration and invasion, and restrained lymph node metastasis, with enhancing radiosensitivity. The effects of LINC00857 on tumor growth were also investigated in nude mice models. Subsequently, the downstream factors, miR‐486‐5p and NEK2, were screened, and the putative regulatory axis was examined. Overall, the regulatory effect of methylation‐mediated LINC00857 overexpression on miR‐486‐5p/NEK2 axis may be a new mechanism for LUAD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCell ProliferationDisease ProgressionDNA MethylationGene Expression Regulation, NeoplasticLung NeoplasmsMicroRNAsRNA, Long NoncodingUp-RegulationAnimalsHumansMiceCell Line, TumorCell MovementMice, NudeNIMA-Related Kinases

Stichwörter der Autor:innen

LINC00857LUADmetastasismethylationradiosensitivity

Substanzen

MicroRNAsMIRN486 microRNA, humanNIMA-Related KinasesRNA, Long NoncodingLINC00857 lnc, humanNEK2 protein, human

Autor:innen und Institutionen

  • Department of Radiation Oncology, Tangshan People's Hospital, Tangshan, China.
  • Department of Thoracic Surgery, Tangshan People's Hospital, Tangshan, China.
  • Department of Breast Surgery, Tangshan People's Hospital, Tangshan, China.

ORCID-Profile: Haoyu Fu

Förderung

  • Key Project Program of Medical Science Research in Hebei Province

Zitieren

APA

Fu, H., Zhang, M., Liu, X., Yang, Y., & Xing, Y. (2024). Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR‐486‐5p/NEK2 axis. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.13765

Vancouver

Fu H, Zhang M, Liu X, Yang Y, Xing Y. Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR‐486‐5p/NEK2 axis. The Clinical Respiratory Journal. 2024. doi:10.1111/crj.13765

BibTeX
@article{Fu2024,
  author = {Fu, Haoyu and Zhang, Mingming and Liu, Xiaohui and Yang, Yiming and Xing, Ying},
  title = {Abnormal methylation mediated upregulation of LINC00857 boosts malignant progression of lung adenocarcinoma by modulating the miR‐486‐5p/NEK2 axis},
  journal = {The Clinical Respiratory Journal},
  year = {2024},
  doi = {10.1111/crj.13765}
}
Kostenlos starten →